GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Specialized Medical Company SCJSC 4019.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

12.39

-0.88%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 1.54bn

FY2022FY2025

Net income

SAR 266.2m

FY2022FY2025

Free cash flow

SAR 228.3m

FY2022FY2025

Shareholders' equity

SAR 1.19bn

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
RevenueSAR 1.54bnSAR 1.44bnSAR 1.37bnSAR 1.21bn
Gross profitSAR 382.9mSAR 362.0mSAR 356.4mSAR 285.7m
Operating incomeSAR 243.4mSAR 237.3mSAR 214.6mSAR 127.7m
Net incomeSAR 266.2mSAR 185.2mSAR 168.7mSAR 103.0m
Diluted earnings per share1.060.740.670.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assetsSAR 2.40bnSAR 2.04bnSAR 2.07bnSAR 1.89bn
Cash and short-term investmentsSAR 249.4mSAR 92.5mSAR 47.8mSAR 21.8m
Total liabilitiesSAR 1.21bnSAR 1.22bnSAR 1.23bnSAR 1.16bn
DebtSAR 826.1mSAR 862.7mSAR 861.7mSAR 815.0m
Shareholders' equitySAR 1.19bnSAR 827.1mSAR 845.0mSAR 731.8m
Shares outstanding250m250m250m250m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operationsSAR 322.7mSAR 383.8mSAR 233.4mSAR 177.5m
Capital spending−SAR 94.5m−SAR 94.3m−SAR 72.8m−SAR 60.9m
Free cash flowSAR 228.3mSAR 289.5mSAR 160.5mSAR 116.6m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
RevenueSAR 406.9mSAR 382.7mSAR 380.0mSAR 368.9mSAR 328.3m
Gross profitSAR 84.9mSAR 101.7mSAR 101.9mSAR 94.3mSAR 49.4m
Operating incomeSAR 80.2mSAR 73.9mSAR 48.6mSAR 40.7mSAR 38.1m
Net incomeSAR 134.0mSAR 66.2mSAR 36.4mSAR 29.6mSAR 26.2m
Diluted earnings per share0.540.270.150.120.10
Cash from operationsSAR 139.0mSAR 107.0m−SAR 43.0mSAR 118.0mSAR 383.0m
Capital spending−SAR 23.0m−SAR 22.0m−SAR 27.0m−SAR 20.0m−SAR 94.0m
Free cash flowSAR 116.0mSAR 85.0m−SAR 70.0mSAR 98.0mSAR 289.0m
Total assetsSAR 2.40bnSAR 2.33bnSAR 2.35bnSAR 2.14bnSAR 2.04bn
Cash and short-term investmentsSAR 249.4mSAR 276.1mSAR 252.3mSAR 65.6mSAR 92.5m
DebtSAR 728.9mSAR 804.9mSAR 855.2mSAR 784.9mSAR 778.9m
Shareholders' equitySAR 1.19bnSAR 1.06bnSAR 992.4mSAR 856.4mSAR 827.1m

Financial ratios

Data as of 17 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin30.9%26.3%25.3%22.6%21.3%
Operating margin21.0%16.6%16.3%11.3%7.4%
Net margin17.3%12.9%12.3%8.5%5.3%
Return on equity22.4%22.4%20.0%14.1%8.2%
Return on assets11.1%9.1%8.1%5.5%3.0%
Free cash flow yield12.5%3.5%2.1%——
Revenue growth301.8%5.1%13.4%14.6%—
Earnings growth440.4%9.7%64.1%83.8%—
Current ratio1.42x0.76x0.87x0.76x1.12x
Debt to equity0.19x1.08x0.59x0.62x0.55x
Equity ratio49.5%40.5%40.7%38.8%37.3%
Interest coverage6.35x5.31x4.61x4.59x4.14x
Buybacks as a share of market value0.0%0.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.4%——
Operating income24.0%——
Net income37.3%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin25.0%25.0%——

Valuation history

At each fiscal year end

FY2025
Price to earnings16.9
Price to sales2.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 7 Jan 2026.

FY2025
Paid in the year0.80

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.